STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Clinical trials for STAGE II PROSTATE ADENOCARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE II PROSTATE ADENOCARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE II PROSTATE ADENOCARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could extra chemotherapy after prostate surgery keep cancer away longer?
Disease control CompletedThis study looked at men with prostate cancer who had their prostate removed. It compared standard treatment (hormone therapy plus radiation) against the same treatment plus chemotherapy (docetaxel). The goal was to see if adding chemo helps prevent the cancer from coming back or…
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 17, 2026 07:04 UTC
-
Shorter radiation course may be just as effective after prostate surgery
Disease control CompletedThis study tested whether a shorter, more intense radiation schedule (hypofractionated) works as well as the standard longer schedule after prostate cancer surgery. About 296 men who had their prostate removed took part. The goal was to see if the shorter treatment could control …
Matched conditions: STAGE II PROSTATE ADENOCARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 12, 2026 13:40 UTC